Drug Discovery and
Materials Development


Elix, Inc. is an AI drug discovery and materials informatics company with the mission of "Rethinking Drug Discovery and Materials Development".

In addition to talented AI researchers and AI engineers, many of the team members have Ph.D. degrees and come from different specialities such as chemistry, biology and physics. This diverse lineup gives us the capability to always be on the cutting-edge of AI research and development.



Our clients are mainly from pharmaceutical companies, chemical manufacturers and academia.

AI Drug Discovery & Materials Informatics

We apply cutting-edge technology in deep learning and machine learning that makes molecular design processes of AI drug discovery and materials informatics far more efficient. Currently we provide proprietary technology with a focus on property prediction, molecular design and retrosynthesis analysis.

Major Functions

  • Predictive models,
  • Generative models,
  • Retrosynthesis models, etc.

Here are some of our major AI drug discovery and materials informatics partners

  • asahikasei
  • astellas
  • bridgestone
  • kyoto univ
  • mitsubishi chemical HD
  • nippon shokubai
  • riken
  • showa denko

Our Partners

We are working together with companies and research institutes in a wide range of industries towards problem solving and value creation.

  • Corporate Partners

    • asahi kasei
    • Astellas Pharma Inc.
    • Bridgestone Corporation
    • CAC Corporation
    • mitsubishi chemical holdings corporation
    • Showa Denko K.K.
    • Honda R&D Co.,Ltd
    • Toppan
  • Research Institutes and Universities

    • kyoto univ.
    • riken
    • chiba univ.
  • Selected Programs

    • block buster tokyo
    • nvidea


We are actively hiring research engineers and project managers for our business expansion!
You are most welcomed if you have experiences in machine learning or if you have a Ph.D in computer science, chemistry, biology or equivalent practical skills and strong interests in AI!

In addition, due to the increasing importance of specialized knowledge and experience in drug discovery and materials informatics, we would love to have people from the pharmaceutical and chemical industries!